Atrial Fibrillation in Beta-Thalassemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital of Ferrara
About this trial
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
Eligibility criteria
Qualifiers
Transfusion-dependent Beta-thalassemia;
Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;
Electrocardiogram performed;
Echocardiogram performed.
Disqualifiers
Age <18 years;
State Of pregnancy;
Inability to give informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
350 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov